B. Evnin Luke's most recent trade in Werewolf Therapeutics Inc was a trade of 58,980 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Jan. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 08 Jan 2026 | 58,980 | 2,309,869 | - | 0.6 | 33,619 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 08 Jan 2026 | 24,678 | 2,368,849 | - | 0.6 | 15,054 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 08 Jan 2026 | 7,716 | 2,393,527 | - | 0.6 | 4,861 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 05 Jan 2026 | 40,761 | 2,413,158 | - | 0.7 | 26,495 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 05 Jan 2026 | 18,378 | 2,453,919 | - | 0.6 | 11,762 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 05 Jan 2026 | 11,915 | 2,401,243 | - | 0.6 | 7,626 | Common Stock |
| Werewolf Therapeutics Inc | Evnin Luke B. | Director | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 30 Dec 2025 | 34,847 | 2,515,827 | - | 0.6 | 21,257 | Common Stock |
| Werewolf Therapeutics Inc | B. Evnin Luke | Director | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 30 Dec 2025 | 24,962 | 2,490,865 | - | 0.6 | 15,476 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 30 Dec 2025 | 18,568 | 2,472,297 | - | 0.6 | 11,698 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 22 Dec 2025 | 108,606 | 2,550,674 | - | 0.6 | 66,250 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 22 Dec 2025 | 71,428 | 2,711,222 | - | 0.6 | 45,000 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 22 Dec 2025 | 59,307 | 2,782,650 | - | 0.7 | 40,922 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 22 Dec 2025 | 35,632 | 2,659,280 | - | 0.6 | 22,448 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 22 Dec 2025 | 16,310 | 2,694,912 | - | 0.7 | 10,602 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 15 Dec 2025 | 23,640 | 2,866,488 | - | 1.1 | 25,295 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 15 Dec 2025 | 14,548 | 2,851,940 | - | 1.0 | 15,275 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 15 Dec 2025 | 9,983 | 2,841,957 | - | 1.1 | 11,381 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 10 Dec 2025 | 37,104 | 2,935,995 | - | 1.1 | 39,330 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 10 Dec 2025 | 28,009 | 2,907,986 | - | 1.1 | 29,970 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.08 per share. | 10 Dec 2025 | 17,858 | 2,890,128 | - | 1.1 | 19,287 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 05 Dec 2025 | 44,570 | 2,973,099 | - | 1.0 | 45,016 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 05 Dec 2025 | 34,041 | 3,017,669 | - | 1.0 | 33,701 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 05 Dec 2025 | 16,568 | 3,051,710 | - | 1.0 | 16,071 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 02 Dec 2025 | 53,416 | 3,068,278 | - | 1.0 | 51,814 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 02 Dec 2025 | 38,043 | 3,158,420 | - | 0.9 | 33,858 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 02 Dec 2025 | 36,726 | 3,121,694 | - | 0.9 | 31,952 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 26 Nov 2025 | 39,096 | 3,196,463 | - | 0.9 | 36,750 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 26 Nov 2025 | 38,978 | 3,248,573 | - | 1.0 | 38,198 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 26 Nov 2025 | 13,014 | 3,235,559 | - | 1.0 | 12,884 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 21 Nov 2025 | 56,992 | 3,314,848 | - | 1.0 | 55,852 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 21 Nov 2025 | 41,287 | 3,371,840 | - | 0.8 | 34,268 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 21 Nov 2025 | 27,297 | 3,287,551 | - | 0.9 | 25,113 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 18 Nov 2025 | 42,566 | 3,439,538 | - | 0.9 | 40,012 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 18 Nov 2025 | 33,776 | 3,482,104 | - | 0.9 | 31,412 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.89 per share. | 18 Nov 2025 | 26,411 | 3,413,127 | - | 0.9 | 23,506 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 13 Nov 2025 | 58,372 | 3,592,061 | - | 1.0 | 57,205 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 13 Nov 2025 | 39,560 | 3,552,501 | - | 0.9 | 36,791 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 13 Nov 2025 | 36,621 | 3,515,880 | - | 1.0 | 34,790 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.11 per share. | 07 Nov 2025 | 43,950 | 3,743,524 | - | 1.1 | 48,785 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 07 Nov 2025 | 35,818 | 3,676,534 | - | 1.1 | 40,833 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 07 Nov 2025 | 31,172 | 3,712,352 | - | 1.2 | 36,783 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 07 Nov 2025 | 26,101 | 3,650,433 | - | 1.1 | 28,450 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 04 Nov 2025 | 90,164 | 3,853,195 | - | 1.2 | 110,000 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 04 Nov 2025 | 34,947 | 3,787,474 | - | 1.2 | 42,286 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 04 Nov 2025 | 30,774 | 3,822,421 | - | 1.2 | 37,544 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 30 Oct 2025 | 73,192 | 4,003,728 | - | 1.3 | 93,686 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 30 Oct 2025 | 60,369 | 3,943,359 | - | 1.3 | 77,876 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 30 Oct 2025 | 55,795 | 4,076,920 | - | 1.4 | 79,787 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 27 Oct 2025 | 86,154 | 4,132,715 | - | 1.6 | 133,539 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 27 Oct 2025 | 46,664 | 4,263,196 | - | 1.7 | 80,262 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.64 per share. | 27 Oct 2025 | 44,327 | 4,218,869 | - | 1.6 | 72,696 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director, Ten Percent Owner | 27 Mar 2025 | 28,113 | 4,312,285 | - | 0.1 | 2,530 | Common Stock | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director, Ten Percent Owner | 27 Mar 2025 | 24,098 | 0 | - | - | Warrant (Right to Buy) | ||
| Werewolf Therapeutics Inc | Luke B. Evnin | Director, Ten Percent Owner | 27 Mar 2025 | 4,015 | 0 | - | - | Warrant (Right to Buy) | ||
| Werewolf Therapeutics Inc | Luke B. Evnin | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 27 Mar 2025 | 2,425 | 4,309,860 | - | 1.0 | 2,546 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,600 | 11,600 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Stock Option (Right to Buy) |